Cooperation of CEO of Deargen U.S.A Bonggun Shin and CDO of Deargen Korea
Read More
임시주주총회 소집공고
Deargen-FarmHannong, a Co-Development Agreement to Develop AI-Powered Crop Protection Products
Deargen expanding to crop protection product.
Read More
Deargen Signs Agreement with Sookmyung Women’s University for Licensing ‘NASH Biomarker’ Technologies
Deargen secured the world’s largest level of NASH patients data.
Read More
Deargen-eFlask, signed a Co-development Agreement for AI-powered drug discovery
Deargen collabotate with eflask to develop new drugs using artificial intelligence.
Read More
Deargen Adds Former Hanmi Pharmaceutical “Dr. Inhwan Bae” as CDO
Deargen adds Dr. Bae In-hwan, who was the research director of Hanmi Pharmaceutical’s synthetic new drug team, as CDO.
Read More
Deargen, awarded the “Best AI Award” in the AI Convergence Bio Health category
Deargen received the “Best AI Award” in the AI Convergence Bio-Health category.
Read More
Kilsoo Kang, CEO of Deargen “Development of AI-specialized new drugs… Promotion of cooperation with global pharmaceutical companies”
The first company that applied “Transformer” technology grafted onto biology.
Read More
AI startups team up with drugmakers for drug repurposing
AI startups team up with drugmakers for drug repurposing
Read More